For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Graybug Vision, Inc.

USPTO Granted Patents = 12

Forward Citations = 9

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Ming Yang (11 out of 12 patents)

Jeffrey L Cleland (11 out of 47 patents)

John G Bauman (7 out of 23 patents)

4. Nu Hoang (7 out of 8 patents)

5. Emmett Manuel Cunningham (7 out of 12 patents)

6. Yun Yu (4 out of 4 patents)

7. Joshua Kays (4 out of 4 patents)

8. Hans-Gottfried Genieser (1 out of 5 patents)

9. Frank Schwede (1 out of 5 patents)

10. Andreas Rentsch (1 out of 4 patents)

11. Per Ekström (1 out of 2 patents)

12. Valeria Marigo (1 out of 3 patents)

13. Francois Paquet-Durand (1 out of 1 patent)

14. Weiling Yu (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 11564890 - Aggregating microparticles for medical therapy (2023-01-31),

2. 11548861 - Drugs and compositions for the treatment of ocular disorders (2023-01-10),

3. 11407781 - Equatorially modified polymer linked multimers of guanosine-3', 5′-cyclic monophosphates (2022-08-09),

4. 11331276 - Aggregating microparticles for medical therapy (2022-05-17),

5. 11160870 - Extended release microparticles and suspensions thereof for medical therapy (2021-11-02),

6. 10485876 - Compounds and compositions for the treatment of ocular disorders (2019-11-26),

7. 10441548 - Aggregating microparticles for medical therapy (2019-10-15),

8. 10117950 - Compounds and compositions for the treatment of ocular disorders (2018-11-06),

9. 10111964 - Compounds and compositions for the treatment of ocular disorders (2018-10-30),

10. 10098965 - Compounds and compositions for the treatment of ocular disorders (2018-10-16),

11. 9956302 - Compounds and compositions for the treatment of ocular disorders (2018-05-01),

12. 9808531 - Compounds and compositions for the treatment of ocular disorders (2017-11-07),

Graybug Vision, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of chronic vision-threatening diseases. Through its proprietary technologies, Graybug is developing a pipeline of potentially first-in-class or best-in-class product candidates designed to deliver sustained pharmacological therapy to the eye. The company's leading product candidate, GB-102, is being evaluated in clinical studies for the treatment of wet age-related macular degeneration and diabetic macular edema.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

12 Patents

#128 in Redwood City, CA

#5,885 in California

#24,831 in US

#46,738 in the World

Redwood City, CA, United States of America

Graybug Vision, Inc.

Forward Citations = 9

14 inventors:

Ming Yang (11 out of 12 patents)

Jeffrey L Cleland (11 out of 47 patents)

John G Bauman (7 out of 23 patents)

4. Nu Hoang (7 out of 8 patents)

5. Emmett Manuel Cunningham (7 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…